|
|||||
|
|
Improving beta-cell secretory function and glycaemia in young-onset type 2 diabetes: A pilot, 12-month,randomized trial of a novel,continuous glucose monitor-guided,rapid treatment intensification strategy incorporating empagliflozin and liraglutide |
|
| Authors: | Timothy L Middleton MPhil Maria I Constantino PhD Margaret McGill MSc Mario D’Souza PhD Dennis K Yue PhD Stephen M Twigg PhD Ted Wu PhD Jencia Wong PhD |
| Affiliation: | 1. Diabetes Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia;2. Diabetes Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
RPA Clinic, Charles Perkins Centre, The University of Sydney, Camperdown, New South Wales, Australia Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia;3. Sydney Local Health District Clinical Research Centre, Camperdown, New South Wales, Australia;4. Diabetes Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia;5. Diabetes Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia RPA Clinic, Charles Perkins Centre, The University of Sydney, Camperdown, New South Wales, Australia |
| Abstract: | |
| Keywords: | β-cell function CGM glycaemic control young-onset type 2 diabetes |
